Shares of The Medicines Company were up nearly 23% on Monday after Novartis said Sunday that it had agreed to buy the single-drug, clinical-stage biotech company for $85 per share. The deal values The Medicines Co mpany at $9.7 billion.
Trending:
Novartis is buying the medicines company for $9.7 billion